Lipocine
Utility Patent Applications
Last updated:
List of all Lipocine patents 41 in total
Status | Patent |
---|---|
Application | Utility: COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS Filling date: 8 Sep 2025 Issue date: 25 Nov 2021 |
Application | Utility: Steroidal Compositions Filling date: 8 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: COMPOSITIONS AND THEIR USE IN ORAL DOSING REGIMENS Filling date: 8 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: 17-HYDROXYPROGESTERONE ESTER-CONTAINING ORAL COMPOSITIONS AND RELATED METHODS Filling date: 8 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: 17-HYDROXYPROGESTERONE ESTER-CONTAINING ORAL COMPOSITIONS AND RELATED METHODS Filling date: 8 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: Steroidal Compositions Filling date: 8 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: BIOAVAILABLE SOLID STATE (17- β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS Filling date: 8 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: Steroidal Compositions Filling date: 8 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: Fixed Dose Oral Testosterone Undecanoate Compositions and Use Thereof Filling date: 8 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions Filling date: 8 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: Liver Disease Filling date: 8 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: Liver Disease Filling date: 8 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: STEROIDAL COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS Filling date: 8 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 23 Jul 2020 |
Application | Utility: ORAL TESTOSTERONE TRIDECANOATE THERAPY Filling date: 8 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: COMPOSITION AND METHOD FOR ORAL DELIVERY OF ANDROGEN PRODRUGS Filling date: 8 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: TESTOSTERONE UNDECANOATE COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 18 Jun 2020 |
Application | Utility: PHARMACEUTICAL COMPOSITION AND METHODS Filling date: 8 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: LIVER DISEASE Filling date: 8 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE Filling date: 8 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions Filling date: 8 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: BIOAVAILABLE SOLID STATE (17- β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS Filling date: 8 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: LIVER DISEASE Filling date: 8 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: (17- )-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use Filling date: 8 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS Filling date: 8 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: (17- )-3-OXOANDROST-4-EN-17YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE Filling date: 8 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: COMPOSITIONS AND THEIR USE IN ORAL DOSING REGIMENS Filling date: 8 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: METHODS FOR IMPROVING QUALITY OF LIFE OR SEXUAL DOMAIN FUNCTION AND COMPOSITION USEFUL IN THE METHODS Filling date: 8 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: 17-Hydroxyprogesterone Ester-Containing Oral Compositions and Related Methods Filling date: 8 Sep 2025 Issue date: 10 Oct 2019 |
Application | Utility: 17-HYDROXYPROGESTERONE ESTER-CONTAINING ORAL COMPOSITIONS AND RELATED METHODS Filling date: 8 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: PHARMACEUTICAL COMPOSITION AND METHODS Filling date: 8 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: ORAL TESTOSTERONE UNDECANOATE THERAPY Filling date: 8 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: LIPOBALANCED LONG CHAIN TESTOSTERONE ESTERS FOR ORAL DELIVERY Filling date: 8 Sep 2025 Issue date: 8 Aug 2019 |
Showing 1 to 41 of 41 patents.